Quick Answer
Amneal Pharmaceuticals, Inc. reported Earnings Per Share Diluted of $0.22 per share for the year ending 2025.
- Amneal Pharmaceuticals, Inc. showed an increase of +157.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Amneal Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), Amneal Pharmaceuticals, Inc.'s Earnings Per Share Diluted has grown by 237.5%.
- Historical annual values: Fiscal year 2025: $0.22 per share | Fiscal year 2024: $0.38 (loss) per share | Fiscal year 2023: $0.48 (loss) per share | Fiscal year 2022: $0.86 (loss) per share | Fiscal year 2021: $0.07 per share | Fiscal year 2020: $0.61 per share | Fiscal year 2019: $2.74 (loss) per share | Fiscal year 2018: $0.16 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: